NCT07019155View on ClinicalTrials.gov

Study of Individuals and Families With Aberrations in DDX41 or Similar Cancer Predisposition Variants

RecruitingOBSERVATIONAL
Enrollment

510

Participants

Timeline

Start Date

July 24, 2025

Primary Completion Date

June 15, 2035

Study Completion Date

June 15, 2035

Conditions
Germline MutationMyelodysplastic SyndromesAcute Myeloid Leukemia
Trial Locations (1)

20892

RECRUITING

National Institutes of Health Clinical Center, Bethesda

All Listed Sponsors
lead

National Cancer Institute (NCI)

NIH

NCT07019155 - Study of Individuals and Families With Aberrations in DDX41 or Similar Cancer Predisposition Variants | Biotech Hunter | Biotech Hunter